Granulocyte colony-stimulating factor
Trials 26 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 73 trials
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 111 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | granulocyte colony-stimulating factor | “Before treatment initiation, subjects were randomized to subsequently receive growth factors, recombinant human erythropoietin (rHuEPO) and/or granulocyte colony-stimulating...” PMID 21876446 ↗ Nov 2011100“This study will examine the effects of granulocyte colony-stimulating factor (G-CSF) on bone marrow stem cells in healthy volunteers with sickle cell trait and determine if...” NCT00005782 ↗ “This multicenter clinical trial evaluated the safety and efficacy of epigenetic modifiers (chidamide and decitabine) in combination with aclarubicin, cytarabine, and...” PMID 32873343 ↗ Sep 2020 “administration of cytokines like granulocyte-colony stimulating factor (G-CSF) and the other is the isolation of stem cells from the marrow and their injection into the hepatic...” NCT03911037 ↗ “After 5 days of granulocyte colony-stimulating factor therapy and a subsequent bone marrow aspiration, patients undergo an intracoronary infusion of autologous...” PMID 37190883 ↗ May 2023 “Administration of a combination of two drugs, granulocyte colony-stimulating factor (G-CSF) and dexamethasone, has been show to stimulate the body to produce a large number of...” NCT00627393 ↗ “Plerixafor used in combination with G-CSF (Granulocyte Colony Stimulating Factor) in 5 Fanconi anemia patients to mobilize and collect a sufficient number of peripheral blood...” NCT02678533 ↗ “* Granulocyte-colony stimulating factor (G-CSF) 5 mcg/kg/day beginning on Day 5 until absolute neutrophil count (ANC) is greater than or equal to 1,000/mm\^3 for 3 consecutive days” NCT00849147 ↗ “We evaluated the role of granulocyte colony-stimulating factor (G-CSF) in patients with severe aplastic anemia (SAA) treated with antithymocyte globulin (ATG) and cyclosporine.” PMID 21233311 ↗ Jan 2011 “This study was designed to evaluate potential clinical benefit of adding Erythropoietin (EPO) in granulocyte-colony stimulating factor (G-CSF)-mobilized stem cell therapy” PMID 29962032 ↗ Aug 2018 “Small studies have yielded divergent results for administration of granulocyte colony-stimulating factor (G-CSF) after acute myocardial infarction.” PMID 24934893 ↗ Jun 2014 “Granulocyte colony-stimulating factor was given in the presence of grade 4 neutropenia or febrile neutropenia until hematological recovery.” NCT03022123 ↗ “a growth factor called granulocyte-colony stimulating factor (G-CSF), which is a natural protein that increases the white blood cell count” NCT00864227 ↗ “Granulocyte colony-stimulating factor (G-CSF) is injected into subcutaneous for three days prior to the blood collection (D-3 to D-1).” NCT02315235 ↗ “Mobilization of bone marrow-derived stem cells with granulocyte colony-stimulating factor (G-CSF) could promote hepatic regeneration.” PMID 22119930 ↗ Nov 2011 “Granulocyte colony-stimulating factor (G-CSF; 300mcg/mL) will be administered for 1 day as a single daily subcutaneous dose.” NCT01412593 ↗ “6.Granulocyte colony-stimulating factor (G-CSF) is given subcutaneously at 300 μg per day until neutrophil recovery.” NCT07512700 ↗ “granulocyte colony-stimulating factor (G-CSF) combined with low-dose cytarabine (Ara-C) and aclacinomycin (ACR)” NCT04168138 ↗ “Participants underwent mobilization with granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days” NCT00396331 ↗ “Administration of granulocyte colony stimulating factor (G-CSF) increases survival times of patients with AH.” PMID 29391265 ↗ Jan 2018 “Granulocyte colony-stimulating factor (G-CSF) and erythropoietin (EPO) will be injected for a total of 4 days” NCT06364150 ↗ “Patients will be stimulated with granulocyte colony-stimulating factor (G-CSF) for 3 consecutive days.” NCT01740869 ↗ “G-CSF (granulocyte colony-stimulating factor) stimulates bone marrow to produce more white blood cells” NCT00165139 ↗ “concurrent granulocyte colony-stimulating factor, 200mg/m2/day subcutaneously daily on days 3-17” NCT03985007 ↗ “Patients received G-CSF (granulocyte colony-stimulating factor) for 5 days” PMID 29880546 ↗ Jun 2018 “Granulocyte Colony-Stimulating Factor(G-CSF) 5 ug/kg/day from day -8 to -5” NCT07441967 ↗ “fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG)” NCT04716114 ↗ “granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days.” NCT00322842 ↗ “granulocyte colony-stimulating factor (G-CSF) 10 µg/kg/day for 4 days” NCT00322491 ↗ “Treatment with G-CSF (Granulocyte colony stimulating factor)” NCT02154269 ↗ “cytokines like granulocyte-colony stimulating factor (G-CSF)” NCT03415698 ↗ “G-CSF (granulocyte colony-stimulating factor)mobilization” NCT00922389 ↗ “intravenous granulocyte colony-stimulating factor (G-CSF)” PMID 28109298 ↗ Jan 2017 “Granulocyte colony-stimulating factor (G-CSF): 50-300μg/d” NCT06394011 ↗ “granulocyte-colony stimulating factor (G-CSF) therapy” PMID 15016484 ↗ Mar 2004 “granulocyte - colony stimulating factor (G-CSF)” NCT00298597 ↗ “granulocyte colony-stimulating factor (G-CSF)” PMID 30664267 ↗ Mar 2019 “G-CSF (Granulocyte colony-stimulating factor)” NCT07367178 ↗ “G-CSF (Granulocyte colony-stimulating factor)” NCT07423728 ↗ “granulocyte colony-stimulating factor (G-CSF)” NCT02451033 ↗ “granulocyte-colony stimulating factor (G-CSF)” NCT01186224 ↗ “Granulocyte Colony-stimulating Factor (G-CSF)” NCT01384565 ↗ “granulocyte colony-stimulating factor (G-CSF)” PMID 22449332 ↗ Mar 2012 “Granulocyte colony-stimulating factor (G-CSF)” NCT01435343 ↗ “G-SCF (Granulocyte-colony stimulating factor)” NCT00040417 ↗ “Granulocyte-colony stimulating factor [G-CSF]” NCT02072811 ↗ “Granulocyte colony-stimulating factor (G-CSF)” NCT04446130 ↗ “Granulocyte Colony Stimulating Factor (G-CSF)” NCT02231242 ↗ “granulocyte colonystimulating factor (G-CSF)” NCT05258799 ↗ “G-CSF Granulocyte-Colony Stimulating Factor” NCT07362810 ↗ “G-CSF Granulocyte-Colony Stimulating Factor” NCT00126100 ↗ “Granulocyte Colony Stimulating Factor” NCT01232504 ↗ |
| Known as | G-CSF | “* Granulocyte-colony stimulating factor (G-CSF) 5 mcg/kg/day beginning on Day 5 until absolute neutrophil count (ANC) is greater than or equal to 1,000/mm\^3 for 3 consecutive days” NCT00849147 ↗67“Donors will receive the white cell growth hormone (G-CSF) as a shot (injection) in their arm once a day for three days before they donate their bone marrow cells.” NCT00231309 ↗ “The drug G-CSF, which is a naturally occurring hormone, causes stem cells to mobilize-that is, to be released from the bone marrow and enter the blood stream.” NCT00005782 ↗ “Recombinant human granulocyte colony-stimulating factor (G-CSF): 300 μg/day, continued until neutrophil recovery and white blood cell count is ≥20,000/μL” NCT06928376 ↗ “Small studies have yielded divergent results for administration of granulocyte colony-stimulating factor (G-CSF) after acute myocardial infarction.” PMID 24934893 ↗ Jun 2014 “a growth factor called granulocyte-colony stimulating factor (G-CSF), which is a natural protein that increases the white blood cell count” NCT00864227 ↗ “Granulocyte colony-stimulating factor(G-CSF) was given 5 ug/kg subcutaneously qd for 6 doses,then qod for other 6 doses(total 12 doses).” NCT02331745 ↗ “Granulocyte colony-stimulating factor (G-CSF) is injected into subcutaneous for three days prior to the blood collection (D-3 to D-1).” NCT02315235 ↗ “Mobilization of bone marrow-derived stem cells with granulocyte colony-stimulating factor (G-CSF) could promote hepatic regeneration.” PMID 22119930 ↗ Nov 2011 “Granulocyte colony-stimulating factor (G-CSF; 300mcg/mL) will be administered for 1 day as a single daily subcutaneous dose.” NCT01412593 ↗ “Patients are randomised in a 1:1 ratio to receive granulocyte-colony stimulating factor (G-CSF) or placebo injection” NCT00747708 ↗ “Granulocyte-colony stimulating factor (G-CSF) is designed to help the bone marrow to make more white blood cells.” NCT00651937 ↗ “Granulocyte colony stimulating factor (GCSF) is supplied in 0.6 mL prefilled syringes for subcutaneous injection.” NCT02215200 ↗ “Adult patients with r/r AML were treated with chidamide, decitabine, cytarabine, aclarubicin, and G-CSF (CDCAG).” PMID 32873343 ↗ Sep 2020 “Granulocyte colony-stimulating factor (G-CSF) and erythropoietin (EPO) will be injected for a total of 4 days” NCT06364150 ↗ “a pilot clinical trial of granulocyte colony stimulating factor (G-CSF) for ALS/MND patients (NCT00397423).” PMID 19727208 ↗ Jun 2009 “Patients will be stimulated with granulocyte colony-stimulating factor (G-CSF) for 3 consecutive days.” NCT01740869 ↗ “Granulocyte colony-stimulating factor (G-CSF) mobilizes CD34+(cluster of differentiation34) cells” NCT06708572 ↗ “Granulocyte colony-stimulating factor (G-CSF or GCSF) is a colony-stimulating factor hormone.” NCT00245037 ↗ “G: G-CSF（300ug/d） d0-9(stop using when White Blood Cell (WBC)\>20\*109/L)” NCT04168138 ↗ “Granulocyte Colony-stimulating Factor (G-CSF) and Erythropoetin (EPO)” NCT01383460 ↗ “Granulocyte-colony stimulating factor (G-CSF) and prednisone” NCT00288626 ↗ “Single-dose Granulocyte colony-stimulating factor (G-CSF)” NCT07692841 ↗ “Granulocyte colony-stimulating factor (G-CSF): 50-300μg/d” NCT06394011 ↗ “Granulocyte Colony Stimulating Factor G-CSF (Neupogen®)” NCT00135928 ↗ “daily subcutaneous injections of G-CSF (10 µg/kg daily)” NCT02248532 ↗ “granulocyte colony-stimulating factor (G-CSF) support” PMID 33684370 ↗ Mar 2021 “granulocyte - colony stimulating factor (G-CSF)” NCT00298597 ↗ “Granulocyte colony-stimulating factor (G-CSF)” NCT04446130 ↗ “Granulocyte Colony Stimulating Factor (G-CSF)” NCT02231242 ↗ “granulocyte colony-stimulating factor (G-CSF)” NCT04716114 ↗ “Granulocyte colony stimulating factor (G-CSF)” NCT06509906 ↗ “Granulocyte Colony-Stimulating Factor (G-CSF)” NCT03674411 ↗ “Granulocyte Colony-Stimulating Factor(G-CSF)” NCT05453552 ↗ “Granulocyte Colony Stimulating Factor (GCSF)” NCT01825551 ↗ “Granulocyte Colony-Stimulating Factor(G-CSF)” NCT05449899 ↗ “Granulocyte Colony-Stimulating Factor(G-CSF)” NCT07692672 ↗ “Granulocyte Colony-Stimulating Factor(G-CSF)” NCT04713956 ↗ “Granulocyte Colony Stimulating Factor (GCSF)” NCT01538862 ↗ “granulocyte colonystimulating factor (G-CSF)” NCT05258799 ↗ |
| Known as | G-CSF（granulocyte colony-stimulating factor ） | “G-CSF（granulocyte colony-stimulating factor ）” NCT02784561 ↗ |
| Known as | G-SCF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00040417 ↗ |
| Known as | Granulocyte-colony stimulating factors | “Granulocyte-colony stimulating factors (G-CSF) can regenerate hepatocyte by fusing with hematopoietic cells” NCT02971306 ↗ |
| Known as | Neupogen | “Granulocyte Colony Stimulating Factor G-CSF (Neupogen®)” NCT00135928 ↗ |
| Known as | rhG-CSF | “Recombinant Human Granulocyte Stimulating Factor (rhG-CSF)” NCT01232504 ↗ |
| Modality | Protein / enzyme biologic | “the growth factor G-CSF has been given to stem cell donors” NCT00082329 ↗ |
| Route | Subcutaneous | “They will receive injections of G-CSF under the skin once a day for 5 days.” NCT00005782 ↗ |